Last reviewed · How we verify
NCT06072625
Enteral Feeding of Premature Babies and Olive Oil Supplementation
NA trial testing Extra virgin organic olive oil (ULTRA PREMIUM) in Premature in 80 participants. Currently enrolling.
31 December 2024
Quick facts
| Lead sponsor | Bursa City Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 1 October 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Extra virgin organic olive oil (ULTRA PREMIUM)
Conditions studied
- Premature — all drugs for Premature →
- Olive Oil — all drugs for Olive Oil →
- Enteral Feeding — all drugs for Enteral Feeding →
Sponsor
Bursa City Hospital
Who can join
Adults 14 Days to 40 Days, any sex, with Premature or Olive Oil. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding. Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values. Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effect of Enteral Organic Extra Virgin Oil Supplementation in Premature Babies on Postnatal Growth, Premature Morbidities, and Oxidative Status.
Dorum BA, Erdoğan A, Çakır SÇ, Yarcı E, et al · · 2026 · PMID 41897040 · DOI 10.3390/children13030327
Verify or expand the search:
- PubMed search for NCT06072625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature
Currently open trials in the same condition.
- NCT07371845 — Effect of Teach-Back Education on Breastfeeding and Bonding in Mothers of Preterm Infants · NA · recruiting
- NCT07049900 — Baby ABS (Abdominal Binder Study) · NA · recruiting
- NCT07154186 — Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients · recruiting
- NCT07088302 — Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates · NA · recruiting
- NCT06812507 — Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their He · NA · recruiting
Other Bursa City Hospital trials
Trials by the same sponsor.
- NCT06925256 — Considering Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography? · NA · not yet recruiting
- NCT07480278 — mTLIP vs QIPB for Postoperative Analgesia in Lumbar Microdiscectomy Surgery · NA · recruiting
- NCT07482345 — Impact of Different Fasting Strategies on Gastric Ultrasound and Anxiety Levels in Children · NA · not yet recruiting
- NCT07370415 — mTLIP vs QIPB for Postoperative Analgesia After Lumbar Instrumentation Surgery · NA · not yet recruiting
- NCT07410000 — Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06072625 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bursa City Hospital
- Last refreshed: 15 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06072625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing